Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock

Clinical trial NCT06122987 · UNKNOWN

Trial details

NCT number: NCT06122987
Sponsor: Kingman Regional Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Septic Shock Shock Sepsis Systemic Inflammatory Response Syndrome

Start date: 2023-12-04
Primary completion: 2024-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.